Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

COCP holding history

Cocrystal Pharma, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

COCP overviewAll 13F holders of COCPFull Q2 2026 holdings

Shares (Q2 2026)
179,628
Value
$188.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of COCP by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026179,628$188.6K<0.1%+55,700+44.9%AddedHolders
Q1 2026123,928$125.2K<0.1%−2,100−1.7%ReducedHolders
Q4 2025126,028$123.4K<0.1%−1,900−1.5%ReducedHolders
Q3 2025127,928$159.9K<0.1%+2,900+2.3%AddedHolders
Q2 2025125,028$186.3K<0.1%−600−0.5%ReducedHolders
Q1 2025125,628$178.4K<0.1%−200−0.2%ReducedHolders
Q4 2024125,828$254.2K<0.1%−4,200−3.2%ReducedHolders
Q3 2024130,028$228.8K<0.1%+200+0.2%AddedHolders
Q2 2024129,828$302.5K<0.1%+3,800+3.0%AddedHolders
Q1 2024126,028$176.0K<0.1%+900+0.7%AddedHolders
Q4 2023125,128$215.0K<0.1%−1,100−0.9%ReducedHolders
Q3 2023126,228$236.0K<0.1%+1,700+1.4%AddedHolders
Q2 2023124,528$298.0K<0.1%+4,700+3.9%AddedHolders
Q1 2023119,828$238.0K<0.1%+5,800+5.1%AddedHolders
Q4 2022114,028$222.0K<0.1%−19,674−14.7%ReducedConverted for a 1-for-12 splitHolders
Q3 20221,604,425$467.0K<0.1%−97,813−5.7%ReducedHolders
Q2 20221,702,238$698.0K<0.1%−2,090−0.1%ReducedHolders
Q1 20221,704,328$937.0K<0.1%−198,597−10.4%ReducedHolders
Q4 20211,902,925$1.24M<0.1%−123,841−6.1%ReducedHolders
Q3 20212,026,766$2.13M<0.1%−567,167−21.9%ReducedHolders
Q2 20212,593,933$3.24M<0.1%−1,660,947−39.0%ReducedHolders
Q1 20214,254,880$5.91M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.